Respiratory syncytial virus laboratory surveillance and hospitalization trends in South Texas

Pediatric Infectious Disease Journal

Volumn 26, Issue 11 SUPPL., 2007, Pages

  Fergie, Jaime ^a,b   Purcell, Kevin ^c,d  

^a Driscoll Childrens Hospital   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c Christus Santa Rosa Health Care   (United States)

^d University of Texas Health Science Center   (United States)

Author keywords

Bronchiolitis; Respiratory syncytial virus; RSV hospitalization; Seasonality

Indexed keywords

CLINICAL EVALUATION; CONFERENCE PAPER; DECISION MAKING; DISEASE CONTROL; DISEASE DURATION; HIGH RISK INFANT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNITED STATES; VIRUS INFECTION;

EID: 37349120078     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318157daae     Document Type: Conference Paper

References (7)

1. The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531-537.
2. Palivizumab Outcomes Registry Study Group. Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from the palivizumab outcomes registry. Pediatr Pulmonol. 2003;35:484-489.
3. Hudak M; and the Palivizumab Outcomes Registry. Palivizumab prophylaxis of RSV disease. Results of 5097 children. The 2001-2002 Outcomes Registry. J Perinatol. 2002;22:619. -Abstract P33].
4. National Respiratory and Enteric Virus Surveillance System (NREVSS). Available at: http://www.cdc.gov/ncidod/dvrd/revb/nrevss/rsvtre1.htm. Accessed July 20, 2007.
5. Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22:857-862.
6. Purcell K, Fergie J. Driscoll Children's Hospital Respiratory Syncytial Virus Database. Risk factors, treatment and hospital course in 3008 infants and young children, 1991 to 2002. Pediatr Infect Dis J. 2004;23:418-423.
7. Purcell K, Fergie J. Relationship between gestational age and outcomes in infants hospitalized for treatment of RSV lower respiratory tract infection. Paper presented at: Infectious Diseases Society of America 40th Annual Meeting; October 6-9, 2005; San Francisco, CA.